PANBELA THERAPEUTICS, INC.

Profile

Company Names

PANBELA THERAPEUTICS, INC.
SUN BIOPHARMA, INC.

Addresses

712 VISTA BLVD #305, WACONIA, MN 55387

Phone Numbers

952-479-1196

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$22,267,438.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-12-21 
$2,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
7
2023-11-02 
$3,322,800.00 
INDEFINITE 
INDEFINITE 
Equity 
6
2022-06-15 
$8,800,000.00 
INDEFINITE 
INDEFINITE 
Equity 
5
2019-08-23 
$2,500,000.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2018-12-21 
$1,358,638.00 
$2,000,000.00 
$641,362.00 
Debt 
3
2018-02-20 
$840,000.00 
$20,000,000.00 
$19,160,000.00 
Equity 
2
2017-02-17 
$1,495,000.00 
$5,000,000.00 
$3,505,000.00 
Debt 
1
2016-06-10 
$1,951,000.00 
$5,000,000.00 
$3,049,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
CULLEN 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
T. 
CULLEN 
EXECUTIVE OFFICER, DIRECTOR
ARTHUR 
J. 
FRATAMICO 
DIRECTOR
SUZANNE 
 
GAGNON 
DIRECTOR
DALVIR 
GILL 
DIRECTOR
DALVIR 
S. 
GILL 
DIRECTOR
SUSAN 
 
HORVATH 
EXECUTIVE OFFICER
SUSAN 
M. 
HORVATH 
EXECUTIVE OFFICER
JEFFREY 
E. 
JACOB 
DIRECTOR
DAVID 
KAYSEN 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
B. 
KAYSEN 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
 
KELLEN 
EXECUTIVE OFFICER
JEFFREY 
MATHIESEN 
DIRECTOR
J. 
ROBERT 
PAULSON 
DIRECTOR
J. 
ROBERT 
PAULSON, JR. 
DIRECTOR
PAUL 
SCHAFFER 
DIRECTOR
PAUL 
W. 
SCHAFFER 
DIRECTOR
D. 
ROBERT 
SCHEMEL 
DIRECTOR
ROBERT 
 
SCHEMEL 
DIRECTOR
ROBERT 
D. 
SCHEMEL 
DIRECTOR
JENNIFER 
K. 
SIMPSON 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-11-02 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-08-23 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-12-21 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-02-20 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-02-17 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
NONE
NONE
LAKE STREET CAPITAL MARKETS, LLC
NONE
NONE
CHARDAN CAPITAL MARKETS LLC